MED earnings date and last-quarter result: next report 2026-08-03, last quarter beat, P/E -5.36. Updated 2026-07-23.
Medifast (MED) Research Hub
Medifast (MED) trades on NYSE, US in the Consumer Cyclical (Specialty Business Services) sector. As of 2026-10-26, shares last closed at 12.11 USD (+2.02%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.36, market cap 0.11B. This hub links to the full technical, earnings and options research available for MED.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Consumer Cyclical (Specialty Business Services) |
|---|---|
| Exchange | NYSE, US |
| Last close | 12.11 USD (+2.02%) |
| 52-week range | 9.39 USD – 13.45 USD |
| Trend regime | Range |
| 14-day RSI | 67.4 (Bullish) |
| Trailing P/E | -5.36 |
| Market cap | 0.11B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for MED
Covered Call on MED: how it works, illustrative setup around the real 12.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MED: how it works, illustrative setup around the real 12.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MED: how it works, illustrative setup around the real 12.11 USD price, max profit/loss, breakeven and when to use it. Educational.
MED technical analysis: range, last 12.11 USD, RSI 67.4, 52w range 9.39 USD–13.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MED in?
Medifast (MED) is classified under Consumer Cyclical (Specialty Business Services), listed on NYSE, US.
Is MED in an uptrend or downtrend?
As of 2026-10-26, MED is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MED's trailing P/E ratio?
MED's trailing P/E is -5.36, with a market cap of 0.11B. See the earnings research page for full valuation detail.
When does MED next report earnings?
MED is next scheduled to report earnings on 2026-08-03.